Redsense presents at Aktiespararnas Kvinnokvällen, October 12
Redsense Medical AB’s board member Susanne Olausson will present the Company at the women’s investor meet Aktiespararnas Kvinnokvällen held in Gothenburg next Monday, on October 12, 14:00-21:00. Olausson’s presentation will begin at 17:30.
Kvinnokvällen is an event that invites female investors, analysts and journalists to meet companies and ask questions to their representatives. In addition to the presenting companies, the event features Karin Wallström Nordén and Gunilla von Platen who will talk about their experiences as entrepreneurs.
The semi-virtual event will be livestreamed but also has a limited number of seats available for physical attendees. The event is free to attend. Those wishing to participate in person (women only) must register on the website: https://www.aktiespararna.se/aktiviteter/kvinnokvallen-i-goteborg-12-oktober-2020
Live and on demand streams from the event will be available for everyone at https://www.aktiespararna.se/tv/live.
“I welcome all Aktiesparare and other interested parties to listen to the presentation and hear about Redsense’s ongoing journey and how the company’s high-tech medical devices save lives and ensure patient safety,” says Susanne Olausson, member of Redsense Medical AB’s Board of Directors.
For more information, please contact:
Patrik Byhmer, CEO Redsense Medical AB (publ)
Phone: +46 35 10 60 30
ABOUT REDSENSE MEDICAL
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovationused for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.